insights_auto
Why is GALT down 4.27%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$2.69
arrow_downward
-4.27%(-0.12) 1D
$2.57
arrow_downward
-4.53% (-0.12)bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$2.80
High
$2.93
Low
$2.67
Mkt. cap
271.35M
Avg. vol.
201.15K
Volume
257.85K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.88M
No. of employees
9
Open
$2.80
High
$2.93
Low
$2.67
Mkt. cap
271.35M
Avg. vol.
201.15K
Volume
257.85K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.88M
No. of employees
9
News stories
From web sources and news partners
BeInCrypto
·
10 hours ago
China, Korea and Taiwan Rush Stock Rescues Before Monday: Can They Help the S&P 500?
Bloomberg.com
·
2 hours ago
S&P 500 at 5,600? Crushing China’s AI Ambitions Has a Price
Crypto Briefing
·
4 hours ago
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
cwibc.co.id
·
1 hour ago
S&P 500 Faces Thanksgiving Week After Sharp Market Selloff
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com